Table 3.
Reimbursement landscape in given countries.
Country | Public health insurance | Private health insurance | Employer sponsored | Consumer funded |
---|---|---|---|---|
US | Products covered depending on insurance scheme | Most products covered, with some limitations | Coverage available through direct negotiation | Out-of-pocket payments possible |
Germany | Statutory health insurance coverage; Digital health product directory (DiGA); selective contracts | Not obliged to cover products but possible through direct negotiation | Not common | Low willingness to pay out-of-pocket |
France | Individual funding decisions; Some experimental coverage options | Some coverage of specific items | Not common | Low willingness to pay out-of-pocket |
UK | No national reimbursement, local organizations for funding and reimbursement | Some products partially covered, but not a common route | Not common | Low willingness to pay out-of-pocket |
Australia | Some schemes available depending on therapeutic area | Some products covered depending on benefit and efficiency gains | Protection insurance providers may fund digital health | Difficult; co-pays common |